Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Short Interest Down 59.8% in December

Awakn Life Sciences Corp. (OTCMKTS:AWKNF) saw a significant decline in short interest in December. As of December 15th, there was short interest totalling 6,800 shares, a decline of 59.8% from the November 30th total of 16,900 shares. Based on an average daily trading volume, of 67,700 shares, the short-interest ratio is currently 0.1 days.

Awakn Life Sciences Price Performance

Shares of AWKNF stock remained flat at $0.07 during trading on Friday. Awakn Life Sciences has a one year low of $0.05 and a one year high of $0.19. The business’s 50 day moving average is $0.08 and its 200 day moving average is $0.08.

About Awakn Life Sciences

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.